Retatrutide activates three receptors GLP-1, GIP, and glucagon while tirzepatide activates two (GLP-1 and GIP)
Both Ro and MEDVi assume chronic ongoing treatment
At the brand-name level, tirzepatide products typically cost $1,000 to $1,100 per month without insurance, slightly higher than brand-name semaglutide
This extended shelf life makes proper vendor storage practices critical, because a well-manufactured product that has been stored at room temperature for months may have lost significant potency before it ever reaches your laboratory
In this article, we compare their mechanisms, results, safety, and ideal use cases so you can make an informed choice with guidance from medical professionals